ERD

DECISION | DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES

01-04-2020

-

30-09-2025

Show more information

Organisation EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF)

LIVERHOPE | SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS

01-01-2017

-

28-02-2023

Show more information

Organisation EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF)

MICROB-PREDICT | MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response

01-01-2019

-

31-03-2025

Show more information

Organisation EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF)

CARBALIVE | Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.

01-05-2015

-

31-01-2021

Show more information

Organisation EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF)

LEOPARD | Liver Electronic Offering Platform with Artificial intelligence-based Devices

01-11-2023

-

31-10-2028

Show more information

Organisation EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF)

IHMCSA | International Human Microbiome Coordination and Support Action

01-05-2021

-

30-04-2024

Show more information

Organisation EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF)

ALIVER | Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)

01-01-2017

-

31-01-2021

Show more information

Organisation EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF)

A-TANGO | NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242

01-03-2021

-

28-02-2026

Show more information

Organisation EUROPEAN FOUNDATION FOR THE STUDY OF CHRONIC LIVER FAILURE (EF-CLIF)

Projects overview

Selected filters:

DECISION | DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES

LIVERHOPE | SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS

MICROB-PREDICT | MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response

CARBALIVE | Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.

LEOPARD | Liver Electronic Offering Platform with Artificial intelligence-based Devices

IHMCSA | International Human Microbiome Coordination and Support Action

ALIVER | Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)

A-TANGO | NOVEL TREATMENT OF ACUTE ON CHRONIC LIVER FAILURE USING SYNERGISTIC ACTION OF G-CSF AND TAK-242